This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA is a proud sponsor of this annual conference.
For more information on this event, click here.
Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.comAs several market-leading PD-(L)1 inhibitors face imminent loss of exclusivity (LoE), the industry confronts a stark reality: technological innovation alone no...
Treatment choice is beneficial for people living with rare diseases (RDs) and competition can drive important economic advantages for payers.
CRA is a proud sponsor of the conference focusing on the intersection of intellectual property and the biopharmaceutical industry, and will explore the law,...
CRA is a proud sponsor of the the largest and most established orphan drug & rare disease meeting of its kind across the globe. From cell and gene therapy,...
